Midatech Pharma Share Discussion Threads

[rakepat37] 09/1/2019 21:07

I tried to buy more today and even on the smallest trade I couldnt buy on line.

[rakepat37] 09/1/2019 21:02

Well it's hit 15p in the USA, this should fly this week

[rakepat37] 09/1/2019 20:30

Looks like we might get some good incoming news soon

[jamtomorrow2] 01/12/2018 12:20

How to waste 6 months and £Xm. Clearly MTD201 isn’t bioequivalent to Sandostatin. But let’s see if we can persuade the FDA that it is.

MTPH - thanks for seeing us after a 6 month wait. Please can we treat MTD201 as bioequivalent to Sandostatin and just carry out a very small Phase 3 trial to confirm?

FDA - no, it’s clearly not. Do a proper big Phase 3 trial.

MTPH - thanks (for nothing).

MTPH (whispering amongst themselves) - sh*t, now what do we do?

[jamtomorrow2] 28/11/2018 13:27

Yes it was L&G and they’ve got lots left.

[jamtomorrow2] 27/11/2018 17:15

looks like L&G are dumping in the 9s but at least someone is buying them. I guess the question is whether L&G will have to go lower to dump the lot. Does seem strange that a major institution would be dumping like this.

I have been wondering about what has happened to those poor souls who sold their companies to Midatech predominantly for shares. Their shares are now pretty much worthless. I wonder if they have all left Midatech in a huff or if not whether we have some disgruntled employees causing us problems and this is one of the reasons for the endless delays in all the projects.

[riddlerone] 22/11/2018 16:01

Spoken like a true politician so is it a sell then ???

[jamtomorrow2] 22/11/2018 11:16

Well they’re going to need money and lots of it unless they can either:-

1). Persuade the FDA to treat MTD201 as bioequivalent (highly unlikely) or

2). Licence MTD201 to Novartis or anybody else interested for a big up-front (highly unlikely).

So big dilution it is then. Years of waiting for MTD201 to be approved and I don’t really know what they’re up to with the head cancer drug but in 3 years they seem to have only treated a couple of patients and I presume the results weren’t great as we’ve have heard any good news by now.

Quite what this highly valuable IP is I have no idea.

[pjballsorts61] 21/11/2018 18:07

Still in but what is your reply?

[jamtomorrow2] 21/11/2018 15:08

I guess you didn’t wait for my reply!

[pjballsorts61] 20/11/2018 19:42

I hold a 1% stake in this! Are you saying get rid?

[jamtomorrow2] 20/11/2018 14:12

L&G dumping again even at these bombed out prices. They clearly think it’s a lost cause. What’s happened to the FDA meeting re MTD201?

[jamtomorrow2] 05/11/2018 18:44

I am now for sure - I wasn’t when I was told this company had multiple shots at success.

[riddlerone] 05/11/2018 15:37

If you are still a shareholder as you say you are that makes you one too

[jamtomorrow2] 05/11/2018 15:09

It was probably placed amongst a selection of gamblers.

[riddlerone] 05/11/2018 14:03

With that amount of stock traded over 1st & 2nd you would expect there to be another RNS of whoever bought the stock.Cant imagine the MMs having such a short book to be able to suck that lot up ,they must have had a buyer.

[jamtomorrow2] 05/11/2018 13:30

And now our second largest shareholder L&G is dumping even at these rock bottom prices. Doesn’t look good to me.

[jamtomorrow2] 03/11/2018 22:14

Nobby - I’d say they have about 2 months of cash left. No idea how you got to your figures. Desperate times.

When I bought into this company I was told that they had multiple shots at success. They then wasted £20m buying what I told them at the time was the worst run pharma company in the whole world and the multiple shots now seem to be very long distance ones. It appears that they now only have one realistic shot and that is 2/3 years away from market and is going to cost them £40m to get to that stage. Fat chance of getting there then without a deal. As they’ve been unable to strike any deals since flotation (apart from blowing £20m on a POS) I’m not holding my breathe. The new CEO doesn’t seem to be inspiring much confidence in the market. As I said - desperate times.

[nobbygnome] 02/11/2018 14:05

There are 2 MMs on the 14.5p offer but the next best is 16p......

[nobbygnome] 02/11/2018 14:03

Wow, the buys are flooding in now the price has moved a little. About to pop IMHO...

[nobbygnome] 02/11/2018 13:33

>> jam

I do not see why they need imminent further funding. They should have £8-9 million in cash now (or at least in the near future- I am assuming half the $6 million is for the 2018 earn out) by my reckoning. I presume they are looking to partner the slow release drug as clearly they cannot run further trials themselves. I was at the Proactive presentation last month and it was very upbeat!

Consequently I have bought 20k today...

Nobby

[ih_433513] 19/10/2018 23:33

The imminent fund raising is going to be hugely dilutionary. Interested parties like Woodford will surely drive a very very hard bargain - maybe even less than 10p - well they have been severely screwed on all previous fund raising and the company has produced very little with the monies raised. Market cap at 17p is only £10m. The company needs £40m unless they can do a big up-front partnering deal on MTD201. You do the maths.

[investopia] 18/10/2018 13:40

Yes, poor fellow

[value viper] 18/10/2018 12:09

Hasn't Woodford got masses of these ?!

[value viper] 18/10/2018 11:54

This is a disaster stock franklyWhat is going on